LBA Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$125K Hold
2,300
0.07% 130
2016
Q4
$134K Hold
2,300
0.07% 122
2016
Q3
$124K Hold
2,300
0.07% 136
2016
Q2
$169K Hold
2,300
0.09% 115
2016
Q1
$147K Hold
2,300
0.09% 121
2015
Q4
$158K Buy
2,300
+1,600
+229% +$106K 0.09% 131
2015
Q3
$41K Sell
700
-1,000
-59% -$63.4K 0.03% 186
2015
Q2
$113K Hold
1,700
0.07% 126
2015
Q1
$110K Hold
1,700
0.07% 130
2014
Q4
$100K Hold
1,700
0.07% 138
2014
Q3
$87K Hold
1,700
0.06% 144
2014
Q2
$82K Hold
1,700
0.07% 146
2014
Q1
$88K Hold
1,700
0.07% 138
2013
Q4
$90K Buy
+1,700
New +$86.6K 0.07% 134

Other funds holding BMY

LBA Wealth Management's BMY Position: Q1 2017 in Review

LBA Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2017 at 2,300 shares worth $125K. The position accounts for 0.07% of the portfolio, ranked #130.

LBA Wealth Management first reported a position in BMY in Q4 2013 and has held it in 14 quarters since. The position peaked at $169K in Q2 2016. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.

  • LBA Wealth Management held 2,300 shares of Bristol-Myers Squibb worth $125K as of Q1 2017.
  • LBA Wealth Management left its Bristol-Myers Squibb share count unchanged in Q1 2017.
  • Bristol-Myers Squibb made up 0.07% of LBA Wealth Management's portfolio in Q1 2017, its #130 holding.
  • LBA Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 14 quarters since.
  • LBA Wealth Management's Bristol-Myers Squibb position peaked at $169K in Q2 2016.
  • 1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.

Based on LBA Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.